Prosecution Insights
Prosecution Insights
Technology area: Chemistry & Materials
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Definitive Biotechnologies LLC is currently managing 1 pending office action in the Chemistry & Materials technology area. This single matter is assigned to 1 distinct examiner, ALABI, OYELEYE A, who also serves as the busiest examiner with 1 pending office action. The prosecution is occurring within 1 distinct art unit, reflecting a focused technical scope for the company's current intellectual property efforts.
With 1 pending office action and 1 distinct examiner, the company's prosecution profile is centralized. The success of the current application in Chemistry & Materials depends on the specific requirements of the 1 distinct art unit involved. ALABI, OYELEYE A is the sole examiner responsible for the 1 pending office action, meaning there is no distribution of workload across different personnel at this time.
The presence of 1 distinct art unit indicates that the company is not currently navigating multiple technical divisions within the patent office. Because there is only 1 pending office action, the prosecution strategy is singular. The relationship with the 1 distinct examiner, ALABI, OYELEYE A, is the defining feature of the company's current patent office activity in the Chemistry & Materials sector.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ALABI, OYELEYE A | 1 | 84.0% | +25.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18493412 | RAPID, MICROFLUIDIC DIAGNOSTIC DEVICE AND METHOD FOR BIOLOGICAL SEX DETERMINATION | ALABI, OYELEYE A | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18493412 | RAPID, MICROFLUIDIC DIAGNOSTIC DEVICE AND METHOD FOR BIOLOGICAL SEX DETERMINATION | ALABI, OYELEYE A | — |
| Art Unit | Apps |
|---|---|
| 1797 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18493412 | RAPID, MICROFLUIDIC DIAGNOSTIC DEVICE AND METHOD FOR BIOLOGICAL SEX DETERMINATION | ALABI, OYELEYE A | 1797 | §102§103 | Non-Final OA | — | Pending | Oct 24, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial